U.S. Soy Sustainability Assurance Protocol (SSAP) Certificates Can Now Be Transferred

Move by USSEC Supports Customers’ Efforts to Verify Sustainable Soy

ST. LOUIS, Sept. 27, 2022 /PRNewswire/ — International customers of U.S. Soy throughout the supply chain are now able to better demonstrate their commitment to sourcing sustainable ingredients. The U.S. Soy Sustainability Assurance Protocol (SSAP) has been expanded to allow the transfer of SSAP certificates up to four times.

U.S. Soybean Export Council; U.S. Soy

U.S. Soy customers have long sought more transparency in the sustainability of their purchases. This change to the SSAP by Soy Export Sustainability, LLC, which is partially funded by the national soybean checkoff, allows customers to keep records of their sustainable U.S. Soy purchases, use these purchases to meet their ESG (Environmental, Social and Governance) goals, and report on their progress toward those goals. Importers will be able to receive a certificate in their name from an exporter, the importer will then be able to transfer certificates to their customers. The certificate has the potential to be transferred a total of four times after export.

“Ensuring sustainable sourcing of products is central to our commitment to responsible supply chains. We are glad to see continuous improvement of the SSAP certifications, as well as the transparent and credible methodologies in place for measuring sustainable performance. Transferable certificates are key to our customers and our business to track and verify that the soy products we source are raised in a sustainable manner, leading to greater sustainability of the global food system,” said Dessislava Barzachka, EA Sustainability Execution Manager, Bunge.

The SSAP, which was developed in 2013, is a verified aggregate approach, audited by third parties, that verifies sustainable soybean production on a national scale. The system is designed to maintain mass balance of verified sustainable soy at each transfer and industry processing calculations are also incorporated into the system. The organization issuing and tracking the certificates is Soy Export Sustainability, LLC.

While this change meets the buyers’ needs for demonstrating their commitment to sourcing sustainable soy in the short-term, in the long-term the change could also help generate demand for their products because of consumer preferences for sustainable products.

Under the SSAP guidelines, U.S. soybean farmers continuously improve their sustainability performance, ensuring an even more sustainable product in the future. U.S. Soy is already recognized as having the lowest carbon footprint versus soy of other origins. In addition, the SSAP includes farm audits conducted by an independent third party – the U.S. Department of Agriculture (USDA). SSAP recently earned Silver Level Equivalence when benchmarked with the Sustainable Agriculture Initiative Platform (SAI Platform)’s Farm Sustainability Assessment (FSA) 3.0. It is also positively benchmarked with the soy sourcing guidelines of the European Feed Manufacturers Federation (FEFAC) through the independent International Trade Centre (ITC) and is recognized by the Consumer Goods Forum’s Sustainable Soy Sourcing Guidelines and the Global Seafood Alliance’s Best Aquaculture Practices.

“U.S. soybean farmers have a strong commitment to sustainability, so we are always exploring how we can support their efforts to verify the sustainability of their products. The SSAP does that, but now with transferable certificates, it allows for that verification to be passed along to their other customers,” said Abby Rinne, Director of Sustainability, U.S. Soybean Export Council (USSEC). USSEC is a founding member of Soy Export Sustainability, LLC focused on differentiating, elevating preference, and attaining market access for U.S. Soy.

About U.S. Soybean Export Council (USSEC)

The U.S. Soybean Export Council (USSEC) focuses on differentiating, elevating preference, and attaining market access for the use of U.S. Soy for human consumption, aquaculture, and livestock feed in 80+ countries internationally. USSEC members represent the soy supply chain including U.S. Soy farmers, processors, commodity shippers, merchandisers, allied agribusinesses, and agricultural organizations. USSEC is funded by the U.S. soybean checkoff, USDA Foreign Agricultural Service (FAS) matching funds, and industry. Visit www.ussec.orgfor the latest information on U.S. Soy solutions and news about USSEC and U.S. Soy internationally.

This news release was partially funded by U.S. Soy farmers, their checkoff and the soy value chain.

Media Contacts:
Chris Samuel Kerrey Kerr-Enskat
Director of Global Communications  Senior Manager, Communications
U.S. Soybean Export Council (USSEC)  U.S. Soybean Export Council (USSEC)
+1.314.306.1273  I  CSamuel@ussec.org +1.515.823.1848  I   kenskat@ussec.org
Bill Raack    Andy Likes
Director Sr. Director
Lambert  Lambert
+1.314.602.0696  I  braack@lambert.com +1.314.606.1878  I  alikes@lambert.com

Logo – https://mma.prnewswire.com/media/1907832/USSEC_USSOY_Logo.jpg

 

As Ebola Spreads, Ugandan Medical Interns Strike Over Safety

As Uganda reports more deaths from the latest Ebola outbreak in the country, medical interns at the hospital handling most of the cases have gone on strike. The interns say they are not being provided with adequate personal protective equipment against the deadly virus, which causes a hemorrhagic fever. Uganda’s health ministry has so far confirmed five deaths and 18 probable fatalities out of 36 cases.

Ugandan Health officials say they are holding talks with striking interns at central Mubende district’s hospital, which is handling most of the country’s spreading Ebola outbreak.

President for the Federation for Uganda Medical Interns, Dr. Musa Lumumba, says there is not enough personal protective gear for the interns at the hospital.

Speaking to VOA by phone, he called on Uganda’s Ministry of Health to urgently address the issue to protect doctors-in-training.

“The issue of not having accommodation, so they stay in communities, which communities have got cases of Ebola,” Lumumba said. Protection of those at the frontline. And those at the frontline are the health care workers.”

Uganda Medical Association President, Dr. Samuel Oledo, told VOA one intern, three staff, and a medical student have been confirmed for exposure to the virus and at least three senior health officers (SHO) are showing symptoms.

“We have 34 interns in Mubende. And we have less than 12 doctors employed on the ground,” Oledo said. “If you have interns and they are pulling out at once, it’s catastrophic. And the justifications are clear, honestly. Results have come out today and one of the SHOs who actually performed surgeries with one of the interns on one case has become positive of Ebola.”

Oledo said they suspect as many as 104 medical students in Mubende hospital have been exposed to the virus.

Uganda’s Ministry of Health has yet to confirm the exposures and infections of students and staff at the hospital.

Ministry spokesman Emmanuel Ainebyoona denied there is a lack of protective equipment there to guard against Ebola.

“All the protective gear to safeguard their life is available,” Ainebyoona said. “But like [with] any other infectious disease, fear will be expected. But we are working to ensure that we engage and counsel. And ensure that there are teams to respond.”

Despite the spreading virus, Uganda’s Health Ministry said the situation is under control but acknowledged that three people suspected of being infected with the virus fled Mubende’s isolation unit on Monday.

Officials say security has been beefed up since to avoid a repeat.

Uganda’s Ebola outbreak was first detected last week in Mubende, a central district, but has since spread to neighboring districts Kyegegwa and Kasanda.

Some schools in Kyegegwa have shut down for two weeks to protect students.

First reports of a possible Ebola outbreak came from Kyegegwa’s Kyaka 11 refugee camp, raising alarm bells of a possible quick spread in the packed camp.

But testing ruled out an outbreak in the camp.

After Mubende’s cases were confirmed, the U.N.’s Refugee Agency UNHCR said it added controlled entry measures at refugee settlements.

“We are stepping up some assistance programs that had been curtailed due to lack of funding since July,” said Matthew Crentsil, the UNHCR Uganda representative. “That is procurement of soap. You would agree with me, this is fundamental in curbing the spread of Ebola.”

Uganda has yet to identify the source of the Ebola outbreak, which is the Sudan strain of the virus.

The Sudan strain is less common than the Zaire strain and has no current, effective vaccine.

Uganda’s last Ebola outbreak in 2019 was the Zaire strain. It last reported a Sudan strain outbreak in 2012.

Source: Voice Of America

Experimental Alzheimer’s Drug Said to Succeed in Slowing Cognitive Decline

An experimental Alzheimer’s drug developed by Eisai and Biogen significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, the companies said Tuesday.

The injected drug, lecanemab, slowed progress of the brain-wasting disease by 27% compared with a placebo, meeting the study’s main goal and offering an apparent win for the companies and potentially for patients and their families desperate for an effective treatment.

Eisai said the results from the 1,800-patient trial prove the longstanding theory that removal of sticky deposits of a protein called amyloid beta from the brains of people with early Alzheimer’s can delay advance of the debilitating disease.

“It’s not a huge effect, but it’s a positive effect,” said Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center in Rochester, Minnesota, adding that the results were extremely important for Alzheimer’s research.

“This means that treating amyloid is a step in the right direction,” he said.

Results considered a “win”

Wall Street analysts, such as Salim Syed at Mizuho Securities, have said the results would be considered a “win” if lecanemab slowed the rate of decline by about 25%, and that shares of both companies could jump on the news.

Shares of Biogen and Eisai were halted, but shares of Eli Lilly, which is also developing an Alzheimer’s drug, were up 6.7% in after-hours trading.Lecanemab, like the companies’ previous drug Aduhelm, is an antibody designed to remove those amyloid deposits. Unlike Aduhelm, lecanemab targets forms of amyloid that have not yet clumped together.

The so-called amyloid hypothesis has been challenged by some scientists, particularly after the U.S. Food and Drug Administration’s controversial approval of Aduhelm in 2021 based on its plaque-clearing ability rather than proof that it helped slow cognitive decline. The decision came after the FDA’s own panel of outside experts had advised against approval.

Aduhelm was the first new Alzheimer’s drug approved in 20 years after a long list of high-profile failures for the industry.

Eisai, leader of the 50-50 partnership’s lecanemab program, is seeking FDA approval under the same accelerated pathway as Aduhelm, with a decision expected in early January. But on Tuesday, the Japanese drugmaker said it would use the new efficacy results to submit lecanemab for traditional FDA review.

The company said it will also seek authorization in Japan and Europe during its current fiscal year, ending March 31.

The Phase III trial evaluated the drug’s ability to reduce cognitive and functional decline based on the Clinical Dementia Rating-Sum of Boxes (CDR-SB), a numerical scale used to quantify the severity of dementia in patients in areas such as memory, orientation, judgment and problem-solving and personal care.

Brain swelling

The rate of ARIA-E, a brain swelling side effect associated with anti-amyloid treatments, was 12.5% in the lecanemab group, versus 1.7% in the placebo group.

While the side effect showed up on imaging, many of these cases were not symptomatic, the companies said. Symptomatic brain swelling was seen in 2.8% of those in the lecanemab group and none of the placebo group, they said.

The trial also tracked the rate of micro hemorrhages in the brain, which occurred at a rate of 17% in the lecanemab group, and 8.7% in the placebo group.

The total incidence of both conditions was 21.3% in the lecanemab group and 9.3% in the placebo group, rates that fell within an expected range, the companies said.

Petersen said the side effect was present, but much less than with Aduhelm, and “certainly tolerable.”

Aduhelm’s approval was a rare bright spot for Alzheimer’s patients, but critics have called for more evidence that amyloid-targeting drugs are worth the cost.

The controversy and reluctance by some payers to cover Aduhelm led Biogen to slash the drug’s price to $28,000 per year from an initial $56,000.

But Medicare, the U.S. government health plan for people 65 and older, this year said it would only pay for Aduhelm if patients were enrolled in a valid clinical trial, which sharply curtailed the medication’s use. Since Alzheimer’s is a disease of aging, an estimated 85% of patients eligible for the drug are covered by the government plan.

The number of Americans living with Alzheimer’s is expected to rise to about 13 million by 2050 from more than 6 million currently, according to the Alzheimer’s Association. Globally, that figure could rise to 139 million by 2050 without an effective treatment, according to Alzheimer’s Disease International.


Source: Voice Of America

Phoenix Software Delivers a Faster JES3plus® with V1R2

Phoenix Software releases updates to its product line in September 2022

EL SEGUNDO, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) — Phoenix Software International, Inc., today announced its intention to make JES3plus V1R2, a derivative work based on IBM’s z/OS® JES3, generally available effective September 30, 2022. This release provides new functionality and integrates continuous delivery items made available over the past twelve months. Thanks to Phoenix’s JES3plus Customer Advisory Council, organizations that migrate to JES3plus can reap the benefits of new features that were ranked in terms of providing true business value to their fellow customers.

JES3plus V1R2

Functional Highlights:

  • Parallel SPOOL I/O – Takes full advantage of the Parallel Access Volumes technology supported by modern mainframe DASD through support for up to eight STARTIO channel programs running concurrently for a single SPOOL extent. This is a major improvement over the traditional JES3 approach of allowing only one STARTIO at a time per SPOOL extent.
  • Reduced Local Lock Contention – Now intrinsic to the way JES3plus operates, multiple I/O completion SRBs execute simultaneously by acquiring the local lock only if and when needed. In addition, if the completing I/O contains requests from only a single address space, the SRB is scheduled directly to that address space rather than to the JES3plus address space.
  • Improved WLM Batch Initiator Balancing – Enabling this facility results in JES3plus placing batch jobs into idle initiators across the JESplex using a target percentage derived from WLM’s initiator allocation counts. Until now this behavior occurred on JES2 systems only.

“Switching to JES3plus is the obvious choice for existing IBM JES3 customers,” said Ed Jaffe, Chief Technology Officer at Phoenix Software International, “and we have reinforced that point by improving performance with empirical results so dramatic they speak for themselves. SPOOL I/O-intensive benchmarks conducted on our z15 showed JES3plus running nearly twice as many jobs as IBM JES3 while simultaneously reducing FICON channel utilization by 92%! Similarly-favorable results were observed when comparing against JES2. And, because our roadmap for enhancements is 100% customer driven, we believe a migration to JES3plus is not only the easiest and least risky choice, it’s the one that just makes sense.”

(E)JES® V6R2

(E)JES V6R2, the latest release of Phoenix Software’s modern z/OS JESplex management tool, includes enhancements for viewing and managing Coupling Facility connections and structures, WLM scheduling environments, job class/groups, sysplex members, and z/OS UNIX mounts. Additionally, support has been added for a filter repository that provides end user ability to save filters and reload them.

Phoenix Software Product Releases: September 2022

Phoenix Software is refreshing its product line this month. Product downloads will be available to customers via the Phoenix Software International Support portal. Visit https://phoenixsoftware.com/support.htm#downloads. New product releases include:

  • (E)JES V6R2
  • CONDOR® z/OS 26.2 z/VSE 32.1
  • CYGNET® z/OS 26.2 z/VSE 32.1
  • Entrypoint® 16.3
  • FALCON® z/OS 26.2 z/VSE 32.1
  • Falcon64® 11.2
  • JES3plus V1R2
  • Key/101® 9.2
  • PHX-Adders®/PHX-Guest® 7.4
  • PHX-BDT® V1R2
  • PHX-KeyPlus® 5.4
  • PHX-ODE® 7.4

About Phoenix Software International

Phoenix Software International, Inc., (https://www.phoenixsoftware.com) is a systems software development company providing advanced software applications to enterprises around the globe. The company offers a wide range of solutions to modern business challenges.

Press contact:
(310) 338-0400
news@phoenixsoftware.com

Analysis summary and raw benchmark SMF data available upon request.

Phoenix Software lança um JES3plus® mais rápido com V1R2

Phoenix Software atualiza sua linha de produtos em setembro de 2022

EL SEGUNDO, Califórnia, Sept. 27, 2022 (GLOBE NEWSWIRE) — A Phoenix Software International, Inc., divulgou hoje a sua intenção de lançar o JES3plus V1R2, trabalho derivado do z/OS® JES3 da IBM, em 30 de setembro de 2022. Esta versão oferece novas funcionalidades que foram disponibilizados nos últimos doze meses. Graças ao Conselho Consultivo de Clientes JES3plus  da Phoenix, as empresas que migram para o JES3plus podem se benefícios dos novos recursos que fornecem valor comercial real para seus clientes.

JES3plus V1R2

Destaques Funcionais:

  • E/S de SPOOL paralelo – Aproveitamento máximo da tecnologia de Volumes de Acesso Paralelo com suporte DASD de mainframe moderno para até oito programas de canal STARTIO em execução simultânea com uma única extensão de SPOOL. Esta é uma grande melhoria em relação à abordagem JES3 tradicional de permitir apenas um STARTIO de cada vez por extensão de SPOOL.
  • Contenção de Bloqueio Local Reduzido – Agora como parte da operação do JES3Plus, vários SRBs de conclusão de E/S são executados simultaneamente, com bloqueio local apenas se e quando necessário. Além disso, se a E/S de conclusão contiver solicitações de apenas um único espaço de endereço, o SRB será agendado diretamente para esse espaço de endereço, em vez do espaço de endereço JES3 plus.
  • Balanceamento aprimorado do Iniciador em Lote WLM – Com o JES3 plus colocando trabalhos em lote em iniciadores ociosos em todo o JESplex usando uma porcentagem alvo derivada das contagens de alocação de iniciadores da WLM. Até agora este comportamento ocorria apenas nos sistemas JES2.

“A adoção do JES3plus é a escolha óbvia para os clientes JES3 da IBM”, disse Ed Jaffe, Diretor de Tecnologia da Phoenix Software International, “e reforçamos esse ponto por meio do aprimoramento do desempenho com resultados empíricos muito impactantes. Os benchmarks intensivos em E/S da SPOOL conduzidos no nosso z15 mostraram que o JES3 plus executou quase o dobro dos trabalhos executados no JES3 da IBM, reduzindo simultaneamente a utilização do canal FICON em 92%! Resultados igualmente favoráveis foram observados na comparação com o JES2. E, como nosso roteiro de melhorias está 100% voltado para o cliente, acreditamos que uma migração para JES3plus seja a escolha mais fácil e menos arriscada, e a que faz mais sentido.”

(E)JES® V6R2

(E)JES V6R2, a mais recente versão da moderna ferramenta de gerenciamento JESplex z/OS da Phoenix Software, inclui melhorias para visualização e gerenciamento de conexões e estruturas de instalações de acoplamento, ambientes de agendamento WLM, classe/grupos de trabalho, membros sysplex e montagens z/OS UNIX. Além disso, adicionamos suporte para um repositório de filtros que fornece ao usuário final a capacidade de salvar e recarregar filtros.

Lançamentos de Produto da Phoenix Software: Setembro de 2022

A Phoenix Software está atualizando sua linha de produtos este mês. Os downloads de produtos estarão disponíveis para os clientes através do portal de suporte da Phoenix Software International. Visite https://phoenixsoftware.com/support.htm#downloads. Novos produtos:

  • (E)JES V6R2
  • CONDOR® z/OS 26.2 z/VSE 32.1
  • CYGNET® z/OS 26.2 z/VSE 32.1
  • Entrypoint® 16.3
  • FALCON® z/OS 26.2 z/VSE 32.1
  • Falcon64® 11.2
  • JES3plus V1R2
  • Key/101® 9.2
  • PHX-Adders®/PHX-Guest® 7.4
  • PHX-BDT® V1R2
  • PHX-KeyPlus® 5.4
  • PHX-ODE® 7.4

Sobre a Phoenix Software International

A Phoenix Software International, Inc., (https://www.phoenixsoftware.com) é uma empresa de desenvolvimento de software de sistemas que fornece aplicativos de software avançados para empresas em todo o mundo. A empresa oferece uma ampla gama de soluções para atender os desafios das empresas modernas.

Contato de Imprensa:
(310) 338-0400
news@phoenixsoftware.com

 Resumo da análise e dados brutos de SMF de referência disponíveis mediante solicitação.

Phoenix Software offre une version plus rapide de JES3plus® avec V1R2

Phoenix Software sort des mises à jour de sa gamme de produits en septembre 2022

EL SEGUNDO, Californie, 27 sept. 2022 (GLOBE NEWSWIRE) — Phoenix Software International, Inc. a annoncé aujourd’hui son intention de rendre JES3plus V1R2, un produit dérivé basé sur z/OS® JES3 d’IBM, généralement disponible à partir du 30 septembre 2022. Cette version offre de nouvelles fonctionnalités et intègre les articles de livraison continue mis à disposition au cours des douze derniers mois. Grâce au Customer Advisory Council (comité consultatif client) de JES3plus de Phoenix, les organisations qui migrent vers JES3plus peuvent récolter les fruits de nouvelles fonctionnalités en termes de provision d’une véritable valeur commerciale à leurs clients.

JES3plus V1R2

Fonctionnalités marquantes :

  • E/S SPOOL parallèles – tire pleinement parti de la technologie Parallel Access Volumes soutenue par le mainframe moderne DASD grâce à la prise en charge de huit programmes de canaux STARTIO pouvant opérer simultanément pour une seule extension SPOOL. Il s’agit d’une amélioration majeure par rapport à l’approche traditionnelle de JES3 consistant à n’autoriser qu’un seul programme STARTIO à la fois par extension SPOOL.
  • Réduction des conflits de verrouillage locaux – élément désormais intrinsèque à la façon dont JES3plus fonctionne, plusieurs SRB de complétion E/S s’exécutent simultanément en acquérant le verrou local uniquement si et quand cela est nécessaire. En outre, si la complétion E/S contient des demandes provenant d’un espace d’adresse unique, le SRB est programmé directement dans cet espace d’adresse plutôt que dans l’espace d’adresse de JES3plus.
  • Amélioration de l’équilibrage de l’initiateur de lots WLM – cette fonctionnalité permet à JES3plus de placer des tâches de lots dans des initiateurs inactifs à travers JESplex à l’aide d’un pourcentage cible dérivé des comptes d’allocation de l’initiateur de WLM. Jusqu’à présent, cela n’était possible que sur les systèmes JES2.

« Passer à JES3plus est le choix évident pour les clients existants d’IBM JES3 », a déclaré Ed Jaffe, directeur technologique de Phoenix Software International. « De plus, nous avons renforcé ce point en améliorant les performances avec des résultats empiriques si spectaculaires qu’ils parlent d’eux-mêmes. Les tests intensifs en E/S SPOOL réalisés sur notre z15  ont montré que JES3plus exécute près de deux fois plus de tâches qu’IBM JES3 tout en réduisant simultanément l’utilisation des canaux FICON de 92 % ! Des résultats tout aussi favorables ont été observés lors de la comparaison avec JES2. Et comme notre feuille de route pour les améliorations est axée à 100 % sur le client, nous pensons qu’une migration vers JES3plus  constitue non seulement le choix le plus simple et le moins risqué, mais aussi le plus logique. »

(E)JES® V6R2

(E)JES V6R2, la dernière version de l’outil de gestion z/OS JESplex moderne de Phoenix Software, comprend des améliorations pour la visualisation et la gestion des connexions et structures de Coupling Facility, des environnements de planification WLM, des groupes/classes de tâches, des membres sysplex et des montages z/OS UNIX. En outre, une prise en charge a été ajoutée pour un référentiel de filtres qui offre à l’utilisateur final la possibilité d’enregistrer des filtres et de les recharger.

Nouvelles versions des produits Phoenix Software : septembre 2022

Phoenix Software met à jour sa gamme de produits ce mois-ci. Les téléchargements de produits seront disponibles pour les clients via le portail d’assistance de Phoenix Software International. Rendez-vous sur https://phoenixsoftware.com/support.htm#downloads. Les nouvelles versions de produits comprennent :

  • (E)JES V6R2
  • CONDOR® z/OS 26.2 z/VSE 32.1
  • CYGNET® z/OS 26.2 z/VSE 32.1
  • Entrypoint® 16.3
  • FALCON® z/OS 26.2 z/VSE 32.1
  • Falcon64® 11.2
  • JES3plus V1R2
  • Key/101® 9.2
  • PHX-Adders®/PHX-Guest® 7.4
  • PHX-BDT® V1R2
  • PHX-KeyPlus® 5.4
  • PHX-ODE® 7.4

À propos de Phoenix Software International

Phoenix Software International, Inc. (https://www.phoenixsoftware.com) est une société de développement de logiciels de systèmes fournissant des applications logicielles avancées aux entreprises du monde entier. La société propose une large gamme de solutions aux défis professionnels modernes.

Contact auprès de la presse :
(310) 338-0400
news@phoenixsoftware.com

 Résumé de l’analyse et données SMF brutes de référence disponibles sur demande.